NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $81,000 | +14.1% | 129,541 | -3.4% | 0.00% | – |
Q3 2020 | $71,000 | -14.5% | 134,090 | +11.6% | 0.00% | – |
Q2 2020 | $83,000 | -7.8% | 120,104 | +0.4% | 0.00% | – |
Q1 2020 | $90,000 | -40.4% | 119,612 | +19.8% | 0.00% | – |
Q4 2019 | $151,000 | -4.4% | 99,845 | -6.3% | 0.00% | – |
Q3 2019 | $158,000 | -75.3% | 106,568 | -78.5% | 0.00% | – |
Q2 2019 | $640,000 | -53.5% | 495,482 | -6.1% | 0.00% | – |
Q1 2019 | $1,377,000 | +62.2% | 527,663 | +2.5% | 0.00% | – |
Q4 2018 | $849,000 | -41.5% | 514,618 | +71.9% | 0.00% | – |
Q3 2018 | $1,452,000 | -21.2% | 299,377 | +1.6% | 0.00% | – |
Q2 2018 | $1,842,000 | -16.7% | 294,678 | +10.7% | 0.00% | -100.0% |
Q1 2018 | $2,211,000 | -17.5% | 266,300 | +1.4% | 0.00% | 0.0% |
Q4 2017 | $2,679,000 | +14.9% | 262,684 | +3.1% | 0.00% | 0.0% |
Q3 2017 | $2,332,000 | +58.6% | 254,882 | +26.6% | 0.00% | – |
Q2 2017 | $1,470,000 | +22.6% | 201,266 | +20.9% | 0.00% | – |
Q1 2017 | $1,199,000 | -57.3% | 166,499 | -65.3% | 0.00% | -100.0% |
Q4 2016 | $2,809,000 | +204.0% | 480,114 | +241.7% | 0.00% | – |
Q3 2016 | $924,000 | -26.7% | 140,498 | +3.5% | 0.00% | – |
Q2 2016 | $1,260,000 | +86.1% | 135,811 | +116.3% | 0.00% | – |
Q1 2016 | $677,000 | -24.9% | 62,791 | -0.3% | 0.00% | – |
Q4 2015 | $902,000 | +274.3% | 62,991 | +449.6% | 0.00% | – |
Q3 2015 | $241,000 | – | 11,462 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|